Navigation Links
Updated Abbott Statement: To Help Respond to Growing Health Crisis, Abbott Increases Aid to $2.5 Million for Haiti Relief and Recovery Efforts
Date:1/18/2010

ABBOTT PARK, Ill., Jan. 18 /PRNewswire-FirstCall/ -- Working directly with humanitarian partners to help address the growing health care crisis, Abbott (NYSE: ABT) is expanding its support for relief efforts in Haiti.  The company will provide $2.5 million in grant funding and donations of critical pharmaceutical and nutritional products to humanitarian aid organizations.  

An initial quantity of Abbott pharmaceutical and nutritional products are already in use in several locations in Haiti as a result of prior work with Direct Relief International to strategically pre-position essential health care products in preparation for potential natural disasters.  These products include antibiotics, rehydration solutions and additional nutritional products that are in critical need following the earthquake in Haiti.  Abbott will continue to work with relief partners to assess and respond to ongoing needs for longer-term recovery efforts.

Video of Abbott products being packed by Direct Relief International for use in Haiti is available at http://agendanyc.com/clients/abbott/preparedness.htm.  Shot in mid-2009, this footage highlights ongoing efforts to pre-position aid.

Background on Abbott's Existing Philanthropic Work in Haiti

Haiti relief efforts build on Abbott's existing philanthropic partnerships to expand access to health care in the country.  Since 2007, Abbott and the Abbott Fund have provided more than $34 million in grants and product donations to help address health needs in Haiti, including maternal and child health, diabetes, HIV/AIDS and malnutrition.

Additional Information on Abbott's Relief Efforts in Haiti

"The recent earthquake has had a devastating impact on Haiti's limited health care system, which was already facing significant challenges," said Catherine V. Babington, president, the Abbott Fund.  "Building on our existing partnerships with humanitarian organizations in Haiti, we are providing funding and product donations to help address the immense and immediate health needs."

Initial support from the Abbott Fund for earthquake recovery efforts includes $150,000 in grants to four of Abbott's trusted humanitarian aid partners: American Red Cross, CARE, Catholic Medical Mission Board and Partners In Health.  All of these organizations have an established presence in Haiti, and are already mobilizing relief efforts in the country.

Abbott also is actively working with AmeriCares, Catholic Medical Mission Board, Direct Relief International, Heart to Heart International, MAP International, Project Hope and additional organizations to identify and distribute critical nutritional and pharmaceutical products that will provide immediate relief for people affected by the earthquake in Haiti.

In addition, Abbott volunteers in the Dallas area are planning to support the efforts of the American Red Cross to respond to the disaster in Haiti.  Through the American Red Cross program, "Ready When the Time Comes," nearly 30 Abbott volunteers have received training over the past year, and are ready to assist with fundraising and other activities in Dallas to support American Red Cross relief efforts.

About Abbott and Abbott Fund

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacturing and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.  The company employs more than 72,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

The Abbott Fund is a philanthropic foundation established by Abbott in 1951.  The Abbott Fund's mission is to create healthier global communities by investing in creative ideas that promote science, expand access to health care and strengthen communities worldwide.  For more information on the Abbott Fund, visit www.abbottfund.org.

SOURCE Abbott

RELATED LINKS
http://www.abbott.com
http://www.abbottfund.org

'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PAREXEL Issues Updated Financial And Operational Information
2. PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
3. AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
4. Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting
5. New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix
6. Bio-Matrix Scientific Group, Inc. Gets Updated Stock Recommendation By KonLin Investment Letter
7. New and Updated Online Tutorials for PROSITE, InterPro, IntAct and UniProt
8. New and Updated Online Tutorials for Textpresso and Gene Ontology
9. Updated Pictures of CEL-SCI Manufacturing Facility Available Online
10. StollerUSA Launches Updated Web site For Growers and Farmers
11. Updated Online Tutorials for DBTSS, Pfam and PDB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... N.J. , Feb. 4, 2016 ContraVir ... focused on the development and commercialization of targeted antiviral ... CEO & Investor Conference 2016, to be held February ... Source Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... on February 10-11, 2016. James Sapirstein , ...
(Date:2/4/2016)... , Feb. 4, 2016 Sinovac Biotech ... a leading provider of biopharmaceutical products in ... of its board of directors received on February 4, ... 2016, from a consortium comprised of PKU V-Ming ( ... Biomedicine Co., Ltd., CICC Qianhai Development ( Shenzhen ...
(Date:2/4/2016)... 2016 Strasbourg, France , ... --> Strasbourg, France , to the US ... is pleased to announce that it acted as an advisor ... in Strasbourg, France , to the US ... --> Transgene (Euronext: TNG), a member of ...
(Date:2/3/2016)...   ViaCyte, Inc ., a leading, privately-held ... cell-derived islet replacement therapy for the treatment of ... that ViaCyte and Janssen Biotech, Inc., one of ... have agreed to consolidate the assets of the ... ViaCyte with an exclusive license to all BetaLogics ...
Breaking Biology Technology:
(Date:2/3/2016)... India , February 3, 2016 ... the new market research report "Automated Fingerprint Identification System ... Search, Latent Search), Application (Banking & Finance, Government, Healthcare, ... published by MarketsandMarkets, the market is expected to be ... CAGR of 21.0% between 2015 and 2020. The transformation ...
(Date:2/2/2016)... 2016 This BCC Research report provides ... reviewing the recent advances in high throughput ‘omic ... field forward. Includes forecast through 2019. ... and opportunities that exist in the bioinformatic market. ... as well as IT and bioinformatics service providers. ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
Breaking Biology News(10 mins):